Application of KAT7 K432 site in colon cancer treatment and/or prognosis evaluation

The invention belongs to the technical field of biotechnology and medical diagnosis, and particularly relates to application of a KAT7K432 site in colon cancer treatment and/or prognosis evaluation. Analysis is carried out based on the KAT7K432 site acetylation modification level and the prognosis level of the clinical patient of the colon cancer, and the result shows that the KAT7K432 site acetylation modification level has significant correlation with the prognosis of the clinical patient. The total survival rate of a patient with a low KAT7K432 site acetylation level is higher, and better prognosis is indicated. The KAT7K432 site is taken as a target spot, so that the proliferation and migration of human colon cancer HCT116 cells can be inhibited, the quality and volume of colon cancer tumors are reduced, and colon cancer is treated. 本发明属于生物技术和医学诊断技术领域，具体涉及KAT7K432位点在结肠癌治疗和/或预后评估中的应用。本发明基于KAT7K432位点乙酰化修饰水平与结肠癌临床患者预后水平进行分析，结果表明，KAT7K432位点乙酰化修饰水平与临床患者预后具有显著相关性。KAT7K432位点乙酰化水平低的患者，其总生存率更高，预示着更好的预后。将KAT7K432位点